Literature DB >> 22014609

Reversible propriospinal myoclonus due to thoracic disc herniation: long-term follow-up.

Wooyoung Jang1, Joong-Seok Kim, Jin Young Ahn, Hee-Tae Kim.   

Abstract

PSM is a rare form of myoclonus of spinal origin. The thoracic level is considered as the myoclonic generator in most cases; however, structural abnormality in conventional magnetic resonance imaging (MRI) related to PSM is more rare. We report the case of a 23-year-old man with PSM with ventral thoracic disc herniation confirmed by conventional MRI, which completely resolved after thoracic discectomy. This case indicates that decompressive surgery might be a valid treatment option.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22014609     DOI: 10.1016/j.jns.2011.09.036

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Propriospinal myoclonus: is it always psychogenic?

Authors:  Rajesh Verma; Heramba Narayan Praharaj; Tushar Premraj Raut; Dheeraj Rai
Journal:  BMJ Case Rep       Date:  2013-07-29

3.  Surgical Treatment of Propriospinal Myoclonus: A Case Report.

Authors:  David L Baker; Thomas J Harkey; Mohammed H Khaleel; Antonio T Howard; Viktoras Palys
Journal:  Cureus       Date:  2022-04-24

Review 4.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 5.  Propriospinal myoclonus: clinical reappraisal and review of literature.

Authors:  Sandra M A van der Salm; Roberto Erro; Carla Cordivari; Mark J Edwards; Johannes H T M Koelman; Tom van den Ende; Kailash P Bhatia; Anne-Fleur van Rootselaar; Peter Brown; Marina A J Tijssen
Journal:  Neurology       Date:  2014-10-10       Impact factor: 9.910

Review 6.  Myoclonus: Pathophysiology and Treatment Options.

Authors:  Ariel Levy; Robert Chen
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.